Olanzapine versus placebo for people with schizophrenia

To systematically assess the clinical effects and safety of olanzapine compared with placebo for people with schizophrenia.

This is a protocol.

Health topics:

Child health > Mental health > Schizophrenia & psychosis

Mental health > Schizophrenia & psychosis > Antipsychotic medication: atypical

Published:

15 April 2019

Authors:

Li Y, Du C, Jiaxiang N, Liqiang Y, Qi F

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Li Y, Du C, Jiaxiang N, Liqiang Y, Qi F. Olanzapine versus placebo for people with schizophrenia. Cochrane Database of Systematic Reviews 2019, Issue 4. Art. No.: CD013310. DOI: 10.1002/14651858.CD013310